Monitoring immune recovery on HIV therapy: critical, helpful, or waste of money in the current era?
- PMID: 38310348
- PMCID: PMC11064897
- DOI: 10.1097/QAD.0000000000003850
Monitoring immune recovery on HIV therapy: critical, helpful, or waste of money in the current era?
Conflict of interest statement
There are no conflicts of interest.
Figures
References
-
- Mutoh Y, Nishijima T, Inaba Y, Tanaka N, Kikuchi Y, Gatanaga H, Oka S. Incomplete recovery of CD4 cell count, CD4 percentage, and CD4/CD8 ratio in patients with human immunodeficiency virus infection and suppressed viremia during long-term antiretroviral therapy. Clin Infect Dis 2018; 67:927–933. - PubMed
-
- Bloch M, John M, Smith D, Rasmussen TA, Wright E. Managing HIV-associated inflammation and ageing in the era of modern ART. HIV Med 2020; 21: (Suppl 3): 2–16. - PubMed
-
- Serrano-Villar S, Sainz T, Lee SA, Hunt PW, Sinclair E, Shacklett BL, et al. . HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality. PLoS Pathog 2014; 10:e1004078. - PMC - PubMed
-
- Vassallo M, Fabre R, Durant J, Lebrun-Frenay C, Joly H, Ticchioni M, et al. . A decreasing CD4/CD8 ratio over time and lower CSF-penetrating antiretroviral regimens are associated with a higher risk of neurocognitive deterioration, independently of viral replication. J Neurovirol 2017; 23:216–225. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical